As for a combo of Anti-CD47 and Anti-PD1 then I can't see this being the hole grail as downregulation of MHC class I expression is a widespread phenomenon used by tumour cells to escape anti-tumor T-cell mediated immune responses. Then there are other checkpoints http://www.ncbi.nlm.nih.gov/pubmed/26883990 mutations http://www.nejm.org/doi/full/10.1056/NEJMoa1604958#t=article and possible lack of costimulation and other things to keep in mind.
Also M2's aren't the only immunosuppressive cells in a tumour. There are Tregs and MDSCs as well. Then there is tumour derived lactate and stromal density which can help with immune evasion too.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM